drugset / Trial / NCT04696822
Bioavailability of Nasal Epinephrine
NaSequentialOpen-labelTreatment
Summary
A Study to Compare the Bioavailability of Epinephrine following a Single Nasal Dose of FMXIN002 Microspheres Powder with Epinephrine 0.3 mg Intramuscular Injection in Adult Subjects with Seasonal Allergic Rhinitis with and without Nasal Allergen Challenge
Timeline
- Start
- 2020-11-01
- Primary completion
- 2021-09-28
- Completion
- 2021-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epinephrine | Other / unclassified | 0.3 mg | Intranasal |
| Subject | Epinephrine | Other / unclassified | 1.6 mg | Intranasal |
| Subject | Epinephrine | Other / unclassified | 3.2 mg | Intranasal |